Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POLR2J3-UPK3BL2 readthrough is a non-coding RNA transcript formed by a readthrough event between the adjacent genes POLR2J3 and UPK3BL2 on chromosome 7. It is classified as a long non-coding RNA (lncRNA) and is not predicted to code for a protein product. While its functional significance is not well-established, expression analyses link it to processes such as immune activation and neuro-retinal plasticity. There are no clinical drugs or biomarker roles attributed to this locus at present, and it is not considered a conventional druggable target.
Not applicable; as a lncRNA, no approved drugs are known to act on this molecule
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POLR2J3-UPK3BL2 readthrough (POLR2J3-UPK3BL2).